Neurocrine Biosciences, Inc. (NBIX)
158.42
-0.63
(-0.40%)
USD |
NASDAQ |
May 15, 16:00
158.45
+0.03
(+0.02%)
After-Hours: 20:00
Neurocrine Biosciences Shareholders Equity (Quarterly) : 3.407B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Soleno Therapeutics, Inc. | 495.80M |
| Biogen, Inc. | 18.65B |
| Nuvalent, Inc. | 1.174B |
| Marker Therapeutics, Inc. | 13.80M |
| Denali Therapeutics, Inc. | 926.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.906B |
| Total Liabilities (Quarterly) | 1.499B |
| Debt to Equity Ratio | 0.1192 |
| Current Ratio | 2.929 |
| Net Debt Paydown Yield | 0.14% |